Correlation Between Sonnet Biotherapeutics and Enliven Therapeutics
Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Enliven Therapeutics, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Enliven Therapeutics.
Diversification Opportunities for Sonnet Biotherapeutics and Enliven Therapeutics
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Sonnet and Enliven is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Enliven Therapeutics go up and down completely randomly.
Pair Corralation between Sonnet Biotherapeutics and Enliven Therapeutics
Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to under-perform the Enliven Therapeutics. In addition to that, Sonnet Biotherapeutics is 1.68 times more volatile than Enliven Therapeutics. It trades about -0.58 of its total potential returns per unit of risk. Enliven Therapeutics is currently generating about -0.26 per unit of volatility. If you would invest 2,866 in Enliven Therapeutics on August 27, 2024 and sell it today you would lose (412.00) from holding Enliven Therapeutics or give up 14.38% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sonnet Biotherapeutics Holding vs. Enliven Therapeutics
Performance |
| Timeline |
| Sonnet Biotherapeutics |
| Enliven Therapeutics |
Sonnet Biotherapeutics and Enliven Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sonnet Biotherapeutics and Enliven Therapeutics
The main advantage of trading using opposite Sonnet Biotherapeutics and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.| Sonnet Biotherapeutics vs. ZyVersa Therapeutics | Sonnet Biotherapeutics vs. Allarity Therapeutics | Sonnet Biotherapeutics vs. Immix Biopharma | Sonnet Biotherapeutics vs. Cns Pharmaceuticals |
| Enliven Therapeutics vs. Capricor Therapeutics | Enliven Therapeutics vs. Soleno Therapeutics | Enliven Therapeutics vs. Bio Path Holdings | Enliven Therapeutics vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |